News for Catalyst Biosciences, Inc. (CBIO)

News for Catalyst Biosciences, Inc.
Date Headline
Sep 11, 2017 08:01 AM Catalyst Biosciences Announces Issuance of Asia Patents Covering Factor IX Hemophilia Program
Sep 07, 2017 08:00 AM Today's Research Reports on Trending Tickers: Athersys and Catalyst Biosciences
Sep 06, 2017 08:01 AM Catalyst Biosciences Announces Positive Factor IX Clinical Data
Sep 05, 2017 08:23 PM ETFs with exposure to Catalyst Biosciences, Inc. : September 6, 2017
Aug 24, 2017 11:01 AM Catalyst Biosciences, Inc. :CBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
Aug 03, 2017 08:00 AM Catalyst Biosciences Reports Second Quarter 2017 Financial Results and Provides Subcutaneous (SQ) Hemophilia Program Update
Jul 06, 2017 08:01 AM Financial Milestone Achieved in Catalyst’s Subcutaneous Factor IX Program
Jun 28, 2017 08:00 AM Catalyst Biosciences’ Factor IX Granted Orphan Drug Designation in Europe
Jun 26, 2017 08:01 AM Catalyst Biosciences Announces Achievement of Stable Normal Factor IX Blood Levels in a Preclinical Subcutaneous Dosing Model
Jun 01, 2017 08:00 AM Today's Research Reports on Stocks to Watch: Catalyst Biosciences and MEI Pharma